Uncomplicated Severe Acute Malnutrition
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Applied MedicalCA - Rancho Santa Margarita
1 programReady to Use Therapeutic Food-Centrally producedN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesAzithromycin
Applied MedicalReady to Use Therapeutic Food-Centrally produced
Clinical Trials (2)
Total enrollment: 1,212 patients across 2 trials
Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)
Start: Jun 2020Est. completion: Dec 2020301 patients
Phase 3Completed
Effects of Three Feeding Regimens on Recovery of Uncomplicated Severely Acute Malnourished Children
Start: Oct 2012Est. completion: Apr 2015911 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.